[2-[(5-methyl-1,2-oxazol-3-yl)oxy]-3-[(5-pentadecyl-1,2-oxazol-3-yl)oxy]propyl] N-(5-bromopentyl)carbamate

C31H52BrN3O6 — CID 19986061

IUPAC[2-[(5-methyl-1,2-oxazol-3-yl)oxy]-3-[(5-pentadecyl-1,2-oxazol-3-yl)oxy]propyl] N-(5-bromopentyl)carbamate
SMILESCCCCCCCCCCCCCCCc1cc(OCC(COC(=O)NCCCCCBr)Oc2cc(C)on2)no1
InChIInChI=1S/C31H52BrN3O6/c1-3-4-5-6-7-8-9-10-11-12-13-14-16-19-27-23-29(34-41-27)37-24-28(39-30-22-26(2)40-35-30)25-38-31(36)33-21-18-15-17-20-32/h22-23,28H,3-21,24-25H2,1-2H3,(H,33,36)
InChIKeyMKPDNHOVAOODJZ-UHFFFAOYSA-N
MW642.68 g/mol
LogP8.72
Rot. Bonds26

About [2-[(5-methyl-1,2-oxazol-3-yl)oxy]-3-[(5-pentadecyl-1,2-oxazol-3-yl)oxy]propyl] N-(5-bromopentyl)carbamate

[2-[(5-methyl-1,2-oxazol-3-yl)oxy]-3-[(5-pentadecyl-1,2-oxazol-3-yl)oxy]propyl] N-(5-bromopentyl)carbamate (PubChem CID 19986061) has the molecular formula C31H52BrN3O6 and a molecular weight of 642.68 g/mol. Its IUPAC name is [2-[(5-methyl-1,2-oxazol-3-yl)oxy]-3-[(5-pentadecyl-1,2-oxazol-3-yl)oxy]propyl] N-(5-bromopentyl)carbamate.

Molecular Properties

Compound Name[2-[(5-methyl-1,2-oxazol-3-yl)oxy]-3-[(5-pentadecyl-1,2-oxazol-3-yl)oxy]propyl] N-(5-bromopentyl)carbamate
PubChem CID19986061
Molecular FormulaC31H52BrN3O6
Molecular Weight642.68 g/mol
Exact Mass641.30
IUPAC Name[2-[(5-methyl-1,2-oxazol-3-yl)oxy]-3-[(5-pentadecyl-1,2-oxazol-3-yl)oxy]propyl] N-(5-bromopentyl)carbamate
SMILESCCCCCCCCCCCCCCCc1cc(OCC(COC(=O)NCCCCCBr)Oc2cc(C)on2)no1
InChIInChI=1S/C31H52BrN3O6/c1-3-4-5-6-7-8-9-10-11-12-13-14-16-19-27-23-29(34-41-27)37-24-28(39-30-22-26(2)40-35-30)25-38-31(36)33-21-18-15-17-20-32/h22-23,28H,3-21,24-25H2,1-2H3,(H,33,36)
InChIKeyMKPDNHOVAOODJZ-UHFFFAOYSA-N
XLogP8.72
TPSA108.85 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds26
Heavy Atoms41
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500642.68
LogP ≤ 58.72
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Analyze [2-[(5-methyl-1,2-oxazol-3-yl)oxy]-3-[(5-pentadecyl-1,2-oxazol-3-yl)oxy]propyl] N-(5-bromopentyl)carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [2-[(5-methyl-1,2-oxazol-3-yl)oxy]-3-[(5-pentadecyl-1,2-oxazol-3-yl)oxy]propyl] N-(5-bromopentyl)carbamate?
The IUPAC name of [2-[(5-methyl-1,2-oxazol-3-yl)oxy]-3-[(5-pentadecyl-1,2-oxazol-3-yl)oxy]propyl] N-(5-bromopentyl)carbamate (CID 19986061) is [2-[(5-methyl-1,2-oxazol-3-yl)oxy]-3-[(5-pentadecyl-1,2-oxazol-3-yl)oxy]propyl] N-(5-bromopentyl)carbamate.
What is the SMILES notation for [2-[(5-methyl-1,2-oxazol-3-yl)oxy]-3-[(5-pentadecyl-1,2-oxazol-3-yl)oxy]propyl] N-(5-bromopentyl)carbamate?
The canonical SMILES for [2-[(5-methyl-1,2-oxazol-3-yl)oxy]-3-[(5-pentadecyl-1,2-oxazol-3-yl)oxy]propyl] N-(5-bromopentyl)carbamate is CCCCCCCCCCCCCCCc1cc(OCC(COC(=O)NCCCCCBr)Oc2cc(C)on2)no1.
What is the InChIKey of [2-[(5-methyl-1,2-oxazol-3-yl)oxy]-3-[(5-pentadecyl-1,2-oxazol-3-yl)oxy]propyl] N-(5-bromopentyl)carbamate?
The InChIKey is MKPDNHOVAOODJZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H52BrN3O6/c1-3-4-5-6-7-8-9-10-11-12-13-14-16-19-27-23-29(34-41-27)37-24-28(39-30-22-26(2)40-35-30)25-38-31(36)33-21-18-15-17-20-32/h22-23,28H,3-21,24-25H2,1-2H3,(H,33,36).
What are the key properties of [2-[(5-methyl-1,2-oxazol-3-yl)oxy]-3-[(5-pentadecyl-1,2-oxazol-3-yl)oxy]propyl] N-(5-bromopentyl)carbamate?
[2-[(5-methyl-1,2-oxazol-3-yl)oxy]-3-[(5-pentadecyl-1,2-oxazol-3-yl)oxy]propyl] N-(5-bromopentyl)carbamate has a molecular weight of 642.68 g/mol, XLogP of 8.72, 26 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for [2-[(5-methyl-1,2-oxazol-3-yl)oxy]-3-[(5-pentadecyl-1,2-oxazol-3-yl)oxy]propyl] N-(5-bromopentyl)carbamate is sourced from PubChem (CID 19986061), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).